Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
benzinga.com/insights/news/25/02/43751821/heres-how-much-you-would-have-made-owning-regeneron-pharmaceuticals-stock-in-the-last-15-years
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 12.37% on an annualized basis producing an average annual return of 24.38%. Currently, Regeneron Pharmaceuticals has a market capitalization of $74.02 billion.
Buying $100 In REGN: If ...
Full…
This story appeared on benzinga.com, 2025-02-14 23:00:12.